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A prospective study of the natural history of idiopathic non-proteinuric
hematuria. In a prospective study of idiopathic glomerulonephritis we
determined the natural history of 49 adult patients (12 primary IgA
nephropathy, 13 thin GBM nephropathy, 20 normal renal tissue and 4
miscellaneous nephropathies) who presented with idiopathic non-protein-
uric non-azotemic hematuria of at least six months duration, in the
absence of hypertension and with a negative urological work-up. The
median follow-up was 11 years with a range of 8 to 14 years. At the end of
the follow-up, renal function had remained stable in all subsets except for
those with miscellaneous disease. Hematuria was still present in all
patients with thin GBM nephropathy, in all but two patients with IgA
nephropathy who went into immunopathological remission, in three out of
four miscellaneous nephropathies, and in seven out of 20 patients with
normal renal tissue. Of the latter patients five had a history suggestive of
urolithiasis at follow-up, which was in the absence of hypercalciuria and
hyperuricosuria. Seven thin GBM patients, five IgA nephropathy patients
and three miscellaneous nephropathies developed hypertension; the inci-
dence of hypertension in each subset was significantly higher than in
patients with normal renal tissue. This study shows that in young adults
with idiopathic chronic non-proteinuric hematuria of four years duration,
renal biopsy will give a definite diagnosis in 86% of the patients, and that
those patients with so-called minor glomerular diseases are at high risk for
hypertension. Those patients with normal renal tissue have a high
incidence of urolithiasis and should have an urological follow-up.
Chronic non-azotemic and non-proteinuric hematuria, either
recurrent macroscopic hematuria or persistent erythrocyturia, is
usually considered, contrary to proteinuric hematuria, to be of
urological origin. Patients presenting with these symptoms are
referred to a urologist and are often subjected to several invasive
diagnostic procedures. However, several nephrological diseases
such as thin glomerular basement membrane nephropathy (thin
GBM nephropathy), IgA nephropathy or interstitial nephritis are
known to present with isolated hematuria [1]. The prognosis of
these hematuric non-proteinuric patients is considered to be
benign, but precise, long-term follow-up data are lacking, and
defined cohorts of patients with appropriate controls are not
available. In this paper we report on the long-term follow-up of 49
patients with chronic non-proteinuric hematuria, both of glomer-
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ular and of non-glomerular origin, who were derived from a
prospective epidemiological study of idiopathic glomerulonephri-
tis conducted between 1978 and 1984 in The Netherlands.
Methods
Patients
Patients were derived from a prospective epidemiological study
conducted between 1978 and 1984 in three regional hospitals in
the Netherlands, which served a total adherent population of 1.5
million. In this study incidence and natural history of idiopathic
glomerulonephritis were determined by renal biopsy according to
strict indications [1]. For a patient to be included in this analysis,
chronic non-azotemic hematuria had to be present for more than
six months, but, to ensure evaluation of patients early in the
natural history of disease, renal biopsy had to be performed within
two years after patient identification. Urological examination,
including intravenous urography, ultrasonography, cystoscopy
and, occasionally, renal arteriography had to be negative. Patients
with known systemic disease, liver disorders, chronic hyperten-
sion, or from known families with hereditary renal disease were
excluded from analysis.
Eighty-one adult patients, aged 16 to 65 years, were biopsied
because of recurrent macroscopic hematuria or persistent eryth-
rocyturia, defined as the consistent presence of more than five
erythrocytes per high power field of centrifuged urine. Of these 81
patients, five patients (1 idiopathic IgA nephropathy, 2 mesangio-
proliferative glomerulonephritis and 2 with interstitial nephritis)
presented with an increased serum creatinine concentration (>
140 j.tmol/liter) and hence were excluded. Two patients with thin
GBM nephropathy and one patient with focal global glomerulo-
sclerosis died during follow-up due to pancreatic carcinoma, lung
carcinoma and a malignant lymphoma. Twenty-four patients were
biopsied because of chronic hematuria in combination with sig-
nificant proteinuria (> 500 mg/day), and therefore were excluded
from this analysis. Thus 49 patients, of whom there were 12
patients with idiopathic IgA nephropathy, 13 patients with thin
GBM nephropathy, 20 patients normal renal tissue and 4 with
miscellaneous nephropathies [focal lymphocytic interstitial ne-
phritis (2), old interstitial nephritis (1), and focal global glomer-
ulosclerosis (1)] were analyzed. In the cases of active interstitial
nephritis the renal disorder was not caused by previous nephro-
toxic medication and was not treated with steroids. None of the
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Table 1. Follow-up findings in patients presenting with chronic non-azotemic non-proteinuric hematuria
1mm unopathological diagnosis
IgAN Thin GBM Normal Miscellaneous°
Initial presentation
No. of patients 12 13 20 4
Malc:female 11:1 8:5 17:3 2:2
Mean age 30 35 30 44
Macroscopic hematuria 6 1 10 1
Microscopic hematuria 6 12 10 3
Proteinuria
<180mg/day 7 8 16 2
180—500 mg/day 5 5 4 2
Initial creatinine clearance ml/min° 109 115 113 93
Total number of glomeruli/section 4b 20 7 17 11 14 4
Focal global glomerulosclerosis 5.0 6.8% 9.6 13.7%° 2.6 4.2% 4.0 4.9%
Follow-up 11 years
Macroscopic hematuria 3 0 0 1
Microscopic hematuria 7 13 7' 2
Hypertension 5 7 1 3
Increase in proteinuria 4 5 2 2
Creatinine clearance ml/min° 100 110 113 75f
Mann-Whitney U test: P = 0.03 thin GBM vs normal
b Mann-Whitney U test: P = 0.002 IgA vs. thin GBM, P = 0.03 IgA vs. normal
Interstitial nephritis (X3), focal global glomerulosclerosis (Xl)d Renal calculi (X5), persistent erythrocyturia of unknown cause (X2)
Determined using the Cockroft formula
Mann-Whitney U-test: P = 0.006 miscellaneous vs. normal
patients with thin GBM disease was consanguinous or had
knowledge of familial hematuria at the time of renal biopsy. All
patients had a normal serum creatinine concentration (< 120
mol/liter) and normal blood pressure at the time of renal biopsy.
Follow-up was done at a median of 11 years, with a range 8 to 14
years. Progression of disease was defined as an increase in serum
creatinine (> 140 mol/1iter, in the absence of therapy that
reduces GFR), development of hypertension (diastolic blood
pressure> 90 mm of Hg and systolic blood pressure  140 mm of
Hg), increase in proteinuria (over 2x initial proteinuria) or a
combination of these three.
Renal biopsies were processed for light microscopy, immuno-
fluorescence and ultrastructural analysis as described elsewhere
[1]. Renal biopsies were classified according to the criteria as
defined by the World Health Organization [21.
Glomerular basement membrane thickness was determined by
the method of Steffes et al [3]. Using this method in adults a value
of less than 260 nm is diagnostic for thin glomerular basal
membranes [4]. The extent of focal global glomerulosclerosis in
renal biopsies of all patients presenting with idiopathic hematuria
was determined by counting the total number of glomeruli and the
amount of scierosed glomeruli in at least five consecutive 2 fiLm
sections, which were selected for the highest amount of glomeruli
per section, stained with silver methenamin hematoxylin eosin.
Protein excretion was determined in a 24-hour urine collection
using the biuret method, and adequate sampling was verified by
measuring creatinine excretion in an automated analyzer based on
the Jaffe reaction. Blood was drawn at the time of renal biopsy
and at follow-up, allowed to clot for one hour at room tempera-
ture, and subsequently one hour on ice, serum was harvested and
snap-frozen in liquid nitrogen. Serum samples were stored at
—70°C until usage. At the time of renal biopsy the routine
laboratory test included antinuclear and rheumatoid factor, anti-
streptolysin titer, classical hemolytic complement activity and liver
function tests. In addition, in five patients with normal renal
histology urinary calcium, phosphate, uric acid and creatinine
excretion were determined. Hypercalciuria was said to exist when
calcium excretion exceeded 4 mgIkgI24 hr, hyperuricosuria was
present if uric acid exceeded 800 mg/24 hr in men or 750 mg/24 hr
in women [5]. Statistical analysis was performed on the SPSS 4.0
statistical package for the Apple computer.
Results
At the entry of the study 18 of the 49 patients were biopsied
because of recurrent macroscopic hematuria; in the remaining 31
patients persistent microscopic erythrocyturia was the indication
for renal biopsy.
Of the 49 patients who were biopsied 67% (33 patients) had
isolated hematuria; their 24-hour protein excretion did not exceed
the physiological limit (< 180 mg/day). The remaining sixteen
patients had proteinuria that corresponded to "trace" to "+"
protein-excretion on the routine dipstick test, which in the 24-
hour protein collection measured 180 to 500 mg/day. After a
median follow-up of 11 years hematuria was still present in 33
patients (10 patients with idiopathic IgA nephropathy, in 7
patients with normal renal tissue and in 3 patients with miscella-
neous nephropathies). All patients with thin GBM nephropathy
showed persistent microscopic hematuria at follow-up. (Table 1)
In IgA nephropathy resolution of hematuria occurred in two
patients who had presented with persistent eiythrocyturia. Both
underwent repeat renal biopsy. Histologically, there was regres-
sion of the mesangial proliferation. Immunofluorescence analysis
showed that the deposition of immunoglobulin IgA1 and comple-
ment C3 had disappeared, and on ultrastructural examination
mesangial electron-dense deposits were no longer demonstrable.
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End follow-up (1992)
Hypertension Increased
Diagnosis N (+ proteinuria) proteinuria P value
IgG nephropathy
Thin GBM
12
13
5 (1)
7 (3)
3
2
0.019a
0003b
Miscellaneous 4 3 (2) 0 0.OOT
Normal 20 1 2
The median follow-up was 11 years.
Hypertension is defined as RR > 140/90 mm/Hg; increased protcinuria
is more than twice initial degree of proteinuria.
Fisher exact test: IgA hypertensives vs. normal renal tissue
b Fisher exact test: thin GBM hypertensives vs. normal renal tissue
C Fisher exact test: miscellaneous hypertensives vs. normal renal tissue
In the group with miscellaneous nephropathies hematuria disap-
peared during follow-up in one patient with active focal interstitial
nephritis.
Of the patients with normal renal tissue 13 (65%) spontane-
ously lost hematuria during follow-up. The median duration of
persistent hematuria in normal renal tissue was 53 months after
renal biopsy. Remission of hematuria was equally distributed over
the patients with macroscopic and microscopic hematuria, al-
though in patients with macroscopic hematuria more symptoms of
urolithiasis (passage of a stone, visible stone fragments in the
urine, symptoms of renal colic) were encountered (Table 3). At
the 11 year follow-up persistent hematuria was still present in
seven patient with normal renal tissue. Five of these patients, of
whom four were originally biopsied because of macroscopic
hematuria, had symptoms suggestive of urolithiasis during follow-
up. In two patients no cause was known for the hematuria (Table
3). Twenty-four hour urinary calcium, phosphate and uric acid
excretion were determined in five of the seven patients with
normal renal tissue who had a history of urolithiasis or persistent
hematuria, and no hypercalciuria or hyperuricosuria could be
demonstrated.
Hypertension was present in all patient groups after a follow-up
period of 11 years (median). In thin GBM nephropathy 7 out of 13
(54%) patients were hypertensive, in IgA nephropathy 5 out of 12
(42%), and the miscellaneous group 3 out of 4. In three patients
with thin GBM nephropathy, one patient with IgA nephropathy
and two patients with miscellaneous nephropathies development
of hypertension coincided with an increase in proteinuria. An
isolated increase in proteinuria was found in two patients with
thin GBM disease, three patients with IgA nephropathy, and two
patients with normal renal tissue (subsequently, diabetes mellitus
of late onset was diagnosed in I of them). Two patients with active
interstitial nephritis showed decreased creatinine clearances at
follow-up (Table 1). The incidence of hypertension was signifi-
cantly higher both in the thin GBM nephropathy and IgA
nephropathy patients, compared to patients with normal renal
tissue on biopsy, as only one patient in the latter group developed
hypertension in the context of a positive family history for
hypertension (Table 2). At follow-up all patients had a normal
serum creatinine concentration.
Because of the increased incidence of hypertension in thin
GBM nephropathy renal biopsies were reassessed for histological
changes. Apart from focal global glomerulosclerosis and some-
Table 3. Natural history of chronic idiopathic hematuria in adultsa
Number of patients 10 10
Male:female ratio 8:2 9:1
Age at follow-up 38 10.7 46 11
Spontaneous resolution" 6 7
Renal calculi within 11 years 4 1
Persistent ery'uria 0 2
times local interstitial fibrosis and tubular atrophy biopsies of thin
GBM disease showed no histological changes. When the numbers
of glomeruli with focal global glomerulosclerosis were counted of
all renal biopsies (Table 1) the 9.6% percentage of sclerosed
glomeruli in thin GBM disease significantly exceeded that of
controls (Mann-Whitney U-test, P = 0.03). In IgA nephropathy
the mean focal global glomerulosclerosis was 5%, which was not
significantly different from normal renal tissue nor from thin
GBM nephropathy. The increased presence of focal global gb-
merulosclerosis in thin GBM nephropathy was neither related to
an increased total number of glomeruli (20 7 glomeruli/section
in thin GBM nephropathy, 17 11 glomeruli/section in normal
renal tissue; P = 0.09), nor caused by long standing hypertension,
as only one patient showed signs of renal microvascular abnor-
malities indicative of hypertension (intima fibrosis of the interlo-
bar arteries and hyalinosis of the afferent arterioles).
Focal global glomerulosclerosis was not secondary to interstitial
nephritis, as none of the biopsies of thin GBM nephropathy
showed substantial interstitial nephritis. Nor was the focal global
glomerulosclerosis in thin GBM disease related to age.
Discussion
In this study we report on the follow-up of 49 patients who
underwent renal biopsy because of chronic non-azotemic idio-
pathic hematuria with proteinuria less than 0.5 g/day ("trace" to
"+" proteinuria on dipstick examination) and with a normal
urological evaluation. From a previous study it was already known
that the prevalence of IgA nephropathy and thin GBM nephrop-
athy was identical in patients biopsied because of chronic hema-
tuna [1]; in this report the prevalence was 24% and 26%,
respectively. This prevalence may differ between countries since it
is influenced by the availability of transmission electron REF
microscopy [6], and organization of the local health care including
urine analysis for insurance, sports and draft registration. It has
been shown that clinical findings at presentation are not helpful in
the differential diagnosis of patients with chronic hematuria, as
patients with urological causes of bleeding could not be distin-
guished from those with glomerular hematuria [4].
The role of renal biopsy in patients with non-proteinuric
non-azotemic hematuria is a topic of debate, particularly after the
introduction of urinary red cell morphology to differentiate be-
tween glomerular or non-glomerular hematuria. The initial claim
[71 that the detection of dysmorphic erythrocytes by phase con-
trast microscopy could differentiate between glomerular and
urological hematuria was refuted in a blind and controlled study
[81. A recent paper showed that, of the dysmorphic erythrocytes
Table 2. Incidence of hypertension in chronic non-azotemic
non-proteinuric hematuria
Macroscopic
hematuria
Microscopic
hematuria
"Normal renal tissue at the time of renal biopsy and negative urological
work-up
"Median duration of persistence of hematuria was 53 months
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identified by phase contrast microscopy, only the acanthocyte,
which is characterized by a ring form with vesicle-like protrusions,
is indicative of glomerular bleeding, with a specificity of 98% and
a sensitivity of 52% provided that over 5% of the urinary
erythrocytes have this configuration [9].
As this acanthocyte is not inducible by changes in osmolarity,
pH or urinary protein concentration it is useful clinically. In fact,
in vitro work has demonstrated that passage of erythrocytes
through the nephron together with some degree of hemolysis is
required for acanthocyte formation [10]. However, patients with
IgA nephropathy and patients with minor glomerular abnormal-
ities, like thin GBM nephropathy, tend to have a low percentage
of acanthocytes in the urine [9]. Therefore renal biopsies remain
necessary to differentiate chronic non-proteinuric glomerular
hematuria from urological causes.
In this study we found that the cause of hematuria corre-
sponded well with the persistence of hematuria during follow-up,
since hematuria remained present in almost all patients with
glomerular or interstitial diseases. Only two patients with IgA
nephropathy were shown to be in clinical, histological and ultra-
structural remission, a finding described previously only in chil-
dren with IgA nephropathy [11]. Conversely, in more than 65% of
the patients with normal renal tissue hematuria disappeared
spontaneously during follow-up or was related to complaints
suggestive of urolithiasis. We determined the excretion of calcium
and uric acid in a 24-hour urine collection of five patients who had
symptoms of urolithiasis with persistent erythrocyturia of un-
known origin, but were unable to demonstrate any hypercalciuria
or hyperuricosuria. In the evaluation of hypercalciuria no mea-
surement of citrate was obtained. The possibility that stone
formation was caused by a low urine citrate concentration has not
been excluded. Similarly, no information about diet was obtained.
It is well known that diet changes can reverse hypercalciuria and
hyperuricosuria [5].
Our study shows that non-proteinuric thin GBM nephropathy
and IgA nephropathy carry an excellent prognosis in relation to
development of renal insufficiency, but are definite risk factors for
the development of hypertension. Similarly, increased proteinuria
(with or without development of hypertension) develops in 36%
of the patients with glomerular hematuria, suggesting a slowly
progressive course of disease.
In contrast to patients with thin GBM nephropathy or IgA
nephropathy, patients with interstitial nephritis show a significant
decrease in creatinine clearance at the end of follow-up, illustrat-
ing a faster progression of disease. How the hypertension in thin
GBM disease is brought about is not known; the increased
presence of focal global glomerulosclerosis suggests a renal origin.
There is evidence that this disease is slowly progressive in some
patients, since they may develop renal insufficiency [12]. The high
incidence of hypertension in thin GBM and IgA nephropathy is
noteworthy considering the fact that the patients with chronic
non-proteinuric hematuria are often not eligible for renal biopsy
and thus are subjected to prolonged follow-up on an outpatient
basis [13], which in our and other's [6] experience often leads to
loss of the patient for medical evaluation or repeated urological
examinations.
As the median duration of persistence of hematuria in normal
renal tissue was four years it is advisable to perform renal biopsy
on those patients in whom chronic non-proteinuric hematuria
remains present for more than four years. In those patients
nephrological causes of hematuria will be found in 86% of the
biopsies. For adequate patient care it is important that these
patients are diagnosed and checked regularly, as development of
hypertension and/or proteinuria in the course of renal disease is
usually an indication of slowly progressive renal disease and may
contribute to development of renal failure. Therefore, we recom-
mend that patients with idiopathic chronic and non-proteinuric
hematuria that is present for over four years, with normal renal
function, blood pressure and a normal urological evaluation, are
subjected to renal biopsy to determine the cause of hematuria.
When renal biopsy does not reveal any nephrological cause for
hematuria patients should be under surveillance of a urologist, as
these patients are liable to develop urolithiasis and occasionally
malignancies [14].
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